Roy Baynes files Form 144 to sell 4,500 shares

Roy Baynes filed a Form 144 notice to sell 4,500 shares of Common Stock via a stock option exercise scheduled for 06/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

Rhea-AI Filing Summary

Roy Baynes filed a Form 144 notice to sell 4,500 shares of Common Stock via a stock option exercise scheduled for 06/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services. The planned method of payment is cash.

Recent sales by the same holder include 4,500, 9,750, 32,750, and 10,000 shares on dates in 04/06/2026–05/05/2026, with reported proceeds shown in dollars.

Insights

Securities Compliance Specialist

Form 144 lists a proposed resale of 4,500 shares by Roy Baynes via option exercise.

The filing identifies the broker-dealer as Morgan Stanley Smith Barney LLC Executive Financial Services and the sale method as a stock option exercise for cash on 06/12/2026. This is a routine regulatory notice required when an affiliate intends to sell restricted or control securities.

Reported prior transactions show multiple disposals in April–May 2026; cash-flow treatment for the proposed sale is to the seller via exercise proceeds. Subsequent SEC transfer or sale filings will confirm completion.

Key Figures

Proposed shares to sell: 4,500 shares Prior sale — 05/05/2026: 4,500 shares Prior sale — 05/01/2026: 9,750 shares +2 more

5 metrics

Proposed shares to sell 4,500 shares proposed sale via stock option exercise on 06/12/2026

Prior sale — 05/05/2026 4,500 shares sale reported with proceeds $209,925.00 on 05/05/2026

Prior sale — 05/01/2026 9,750 shares sale reported with proceeds $431,145.00 on 05/01/2026

Prior sale — 04/14/2026 32,750 shares sale reported with proceeds $1,352,130.00 on 04/14/2026

Prior sale — 04/06/2026 10,000 shares sale reported with proceeds $330,000.00 on 04/06/2026

Key Terms

Form 144, Stock Option Exercise, Issuer, Broker‑Dealer

4 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"Securities To Be Sold | Stock Option Exercise | ISSUER"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Issuer regulatory

"Securities To Be Sold | ISSUER"

Broker‑Dealer financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TVTX shares does the Form 144 propose to sell?

The Form 144 proposes to sell 4,500 shares. The sale is described as a stock option exercise to occur on 06/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services, with cash listed as the payment method.

Who is the selling party named in the filing for TVTX?

The selling party is named as Roy Baynes. The notice lists his address and shows prior sales in April–May 2026; the broker-dealer handling the proposed exercise is Morgan Stanley Smith Barney LLC Executive Financial Services.

What recent sales by the same holder are disclosed in the Form 144?

The filing discloses prior sales of 4,500, 9,750, 32,750, and 10,000 shares on dates between 04/06/2026 and 05/05/2026, with dollar proceeds reported for each transaction in the excerpt.

What method and broker are listed for the proposed TVTX sale?

Method: Stock Option Exercise with payment by cash. Broker-dealer: Morgan Stanley Smith Barney LLC Executive Financial Services (1 New York Plaza, 8th Floor), as stated in the filing.

Does the Form 144 confirm the sale has occurred?

No. The Form 144 is a notice of a proposed sale of 4,500 shares scheduled for 06/12/2026; completion and any subsequent market sale would be reported in later filings if and when they occur.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001680739
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	ROY BAYNES
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4500	225000.00	92992905	06/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2026	Stock Option Exercise	ISSUER			4500	06/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROY BAYNES 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	05/05/2026	4500	209925.00
ROY BAYNES 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	05/01/2026	9750	431145.00
ROY BAYNES 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/14/2026	32750	1352130.00
ROY BAYNES 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/06/2026	10000	330000.00

144: Remarks and Signature

Remarks
Date of Notice	06/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/17/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Roy Dennis Baynes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)